Joseph Kauer

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 19

Top Topics

Multiple Myeloma

Tyrosine Kinase

Chronic Lymphocytic Leukemia

Top Venues

Hematological oncology

Leukemia & lymphoma

This page only lists publications with an associated author ORCID identifier.

Publications

Samuel J Holzmayer, Joseph Kauer, Jonas Mauermann, Tobias Roider, Melanie Märklin
Asciminib Maintains Antibody-Dependent Cellular Cytotoxicity against Leukemic Blasts. Cancers 16 (7) (2024)
Philipp M Roessner, Isabelle Seufert, Vicente Chapaprieta, Ruparoshni Jayabalan, Hannah Briesch, Ramon Massoni-Badosa, Pavle Boskovic, Julian Beckendorff, Tobias Roider, Lavinia Arseni, Mariana Coelho, Supriya Chakraborty, Alicia Vaca, Mariela Sivina, Markus Muckenhuber, Sonia Rodriguez-Rodriguez, Alice Bonato, Sophie A Herbst, Marc Zapatka, Clare Sun, Helene Kretzmer, Thomas Naake, Peter-Martin Bruch, Felix Czernilofsky, Elisa Ten Hacken, Martin Schneider, Dominic Helm, Deyan Yordanov Yosifov, Joseph Kauer, Alexey V Danilov, Moritz Bewarder, Kristina Heyne, Christof Schneider, Stephan Stilgenbauer, Adrian Wiestner, Jan-Philipp Mallm, Jan A Burger, Dimitar G Efremov, Peter Lichter, Sascha Dietrich, José Ignacio Martín-Subero, Karsten Rippe, Martina Seiffert
T-bet suppresses proliferation of malignant B cells in chronic lymphocytic leukemia. Blood (2024)
Julia Marie Unglaub, Richard F Schlenk, Jan M Middeke, Stefan W Krause, Sabrina Kraus, Hermann Einsele, Michael Kramer, Sven Zukunft, Joseph Kauer, Simon Renders, Elena Katelari, Christoph Schliemann, Caroline Pabst, Thomas Luft, Peter Dreger, Christoph Röllig, Martin Bornhäuser, Carsten Muller-Tidow, Tim Sauer
Venetoclax-based salvage therapy as bridge-to-transplant is feasible and effective in patients with relapsed/refractory AML. Blood advances (2024)
Philipp M Roessner, Isabelle Seufert, Vicente Chapaprieta, Ruparoshni Jayabalan, Hannah Briesch, Ramon Massoni-Badosa, Pavle Boskovic, Julian Benckendorff, Tobias Roider, Lavinia Arseni, Mariana Coelho, Supriya Chakraborty, Alicia M Vaca, Mariela Sivina, Markus Muckenhuber, Sonia Rodriguez-Rodriguez, Alice Bonato, Sophie A Herbst, Marc Zapatka, Clare Sun, Helene Kretzmer, Thomas Naake, Peter-Martin Bruch, Felix Czernilofsky, Elisa Ten Hacken, Martin Schneider, Dominic Helm, Deyan Yordanov Yosifov, Joseph Kauer, Alexey V Danilov, Moritz Bewarder, Kristina Heyne, Christof Schneider, Stephan Stilgenbauer, Adrian Wiestner, Jan-Philipp Mallm, Jan A Burger, Dimitar G Efremov, Peter Lichter, Sascha Dietrich, José Ignacio Martin-Subero, Karsten Rippe, Martina Seiffert
T-bet suppresses proliferation of malignant B cells in chronic lymphocytic leukemia. Blood 144 (5) (2024)
Samuel J Holzmayer, Joseph Kauer, Jonas Mauermann, Tobias Roider, Melanie Märklin
Asciminib Maintains Antibody-Dependent Cellular Cytotoxicity against Leukemic Blasts. Cancers 16 (7) (2024)
Samuel J Holzmayer, Joseph Kauer, Jonas Mauermann, Tobias Roider, Melanie Märklin
Asciminib Maintains Antibody-Dependent Cellular Cytotoxicity against Leukemic Blasts. Cancers 16 (7) (2024)
Philipp M Roessner, Isabelle Seufert, Vicente Chapaprieta, Ruparoshni Jayabalan, Hannah Briesch, Ramon Massoni-Badosa, Pavle Boskovic, Julian Benckendorff, Tobias Roider, Lavinia Arseni, Mariana Coelho, Supriya Chakraborty, Alicia M Vaca, Mariela Sivina, Markus Muckenhuber, Sonia Rodriguez-Rodriguez, Alice Bonato, Sophie A Herbst, Marc Zapatka, Clare Sun, Helene Kretzmer, Thomas Naake, Peter-Martin Bruch, Felix Czernilofsky, Elisa Ten Hacken, Martin Schneider, Dominic Helm, Deyan Yordanov Yosifov, Joseph Kauer, Alexey V Danilov, Moritz Bewarder, Kristina Heyne, Christof Schneider, Stephan Stilgenbauer, Adrian Wiestner, Jan-Philipp Mallm, Jan A Burger, Dimitar G Efremov, Peter Lichter, Sascha Dietrich, José Ignacio Martin-Subero, Karsten Rippe, Martina Seiffert
T-bet suppresses proliferation of malignant B cells in chronic lymphocytic leukemia. Blood 144 (5) (2024)
Joseph Kauer, Lilli Sophie Sester, Katharina Kriegsmann, Niels Weinhold, Michael Ober, Carsten Müller-Tidow, Hartmut Goldschmidt, Marc-Steffen Raab, Sandra Sauer
Cyclophosphamide etoposide dexamethasone as salvage and bridging therapy in relapsed refractory and extramedullary multiple myeloma. Hematological oncology (2023)
Joseph Kauer, Lilli Sophie Sester, Katharina Kriegsmann, Niels Weinhold, Michael Ober, Carsten Müller-Tidow, Hartmut Goldschmidt, Marc-Steffen Raab, Sandra Sauer
Cyclophosphamide etoposide dexamethasone as salvage and bridging therapy in relapsed refractory and extramedullary multiple myeloma. Hematological oncology (2023)
Joseph Kauer, Lilli Sophie Sester, Katharina Kriegsmann, Niels Weinhold, Michael Ober, Carsten Müller-Tidow, Hartmut Goldschmidt, Marc-Steffen Raab, Sandra Sauer
Cyclophosphamide etoposide dexamethasone (CED) as salvage and bridging therapy in relapsed refractory and extramedullary multiple myeloma. Hematological oncology (2023)
Joseph Kauer, Melanie Märklin, Martin Pflügler, Sebastian Hörner, Clemens Hinterleitner, Claudia Tandler, Gundram Jung, Helmut R Salih, Jonas S Heitmann
BCR::ABL1 tyrosine kinase inhibitors hamper the therapeutic efficacy of blinatumomab in vitro. Journal of cancer research and clinical oncology 148 (10) (2022)
Nick Seyfried, Can Yurttas, Markus Burkard, Benedikt Oswald, Alexander Tolios, Franziska Herster, Joseph Kauer, Tarkan Jäger, Ingmar Königsrainer, Karolin Thiel, Markus Quante, Hans-Georg Rammensee, Sascha Venturelli, Matthias Schwab, Alfred Königsrainer, Stefan Beckert, Markus W Löffler
Prolonged Exposure to Oxaliplatin during HIPEC Improves Effectiveness in a Preclinical Micrometastasis Model. Cancers 14 (5) (2022)
Sarah M Greiner, Melanie Märklin, Samuel Holzmayer, Kübra Kaban, Sophie Meyer, Clemens Hinterleitner, Claudia Tandler, Ilona Hagelstein, Gundram Jung, Helmut R Salih, Jonas S Heitmann, Joseph Kauer
Identification of CD105 (endoglin) as novel risk marker in CLL. Annals of hematology 101 (4) (2022)
Sebastian Hörner, Moustafa Moustafa-Oglou, Karin Teppert, Ilona Hagelstein, Joseph Kauer, Martin Pflügler, Kristina Neumann, Hans-Georg Rammensee, Thomas M Metz, Andreas Herrmann, Helmut R Salih, Gundram Jung, Latifa Zekri
IgG-Based Bispecific Anti-CD95 Antibodies for the Treatment of B Cell-Derived Malignancies and Autoimmune Diseases. Cancers 14 (16) (2022)
Joseph Kauer, Fabian Vogt, Ilona Hagelstein, Sebastian Hörner, Melanie Märklin, Stefanie Maurer, Helmut R Salih, Gundram Jung, Latifa Zekri
CD18 Antibody Application Blocks Unwanted Off-Target T Cell Activation Caused by Bispecific Antibodies. Cancers 13 (18) (2021)
Joseph Kauer, Sebastian Hörner, Lukas Osburg, Stefanie Müller, Melanie Märklin, Jonas S Heitmann, Latifa Zekri, Hans-Georg Rammensee, Helmut R Salih, Gundram Jung
Tocilizumab, but not dexamethasone, prevents CRS without affecting antitumor activity of bispecific antibodies. Journal for immunotherapy of cancer 8 (1) (2021)
Jonas S Heitmann, Ilona Hagelstein, Clemens Hinterleitner, Lukas Osburg, Helmut R Salih, Joseph Kauer, Melanie Märklin
Fc gamma receptor expression serves as prognostic and diagnostic factor in AML. Leukemia & lymphoma 61 (10) (2020)
Latifa Zekri, Fabian Vogt, Lukas Osburg, Stefanie Müller, Joseph Kauer, Timo Manz, Martin Pflügler, Andreas Maurer, Jonas S Heitmann, Ilona Hagelstein, Melanie Märklin, Sebastian Hörner, Tilmann Todenhöfer, Carsten Calaminus, Arnulf Stenzl, Bernd Pichler, Christian la Fougère, Marc A Schneider, Hans-Georg Rammensee, Lars Zender, Bence Sipos, Helmut R Salih, Gundram Jung
An IgG-based bispecific antibody for improved dual targeting in PSMA-positive cancer. EMBO molecular medicine 13 (2) (2020)
Joseph Kauer, Karolin Schwartz, Claudia Tandler, Clemens Hinterleitner, Malte Roerden, Gundram Jung, Helmut R Salih, Jonas S Heitmann, Melanie Märklin
CD105 (Endoglin) as negative prognostic factor in AML. Scientific reports 9 (1) (2019)